News


Dec 22 2016

Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement

Transaction to create NASDAQ-listed pharmaceutical company focused on the development and commercialization of ear, nose, and throat (ENT) products Gregory J. Flesher to be Named President and Chief Executive Officer of the Combined Company BOSTON, Mass., IRVINE, Calif., and REHOVOT, Israel — (BUSINESS WIRE) — Dec. 22, 2016 — Tokai Pharmaceuticals Inc. (NASDAQ: TKAI) and […]

Mar 10 2016

OticPharma to Present at the 28th Annual ROTH Conference

IRVINE, Calif. and REHOVOT, Israel, March 10, 2016 /PRNewswire/ — OticPharma, Ltd., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced that Gregory J. Flesher, chief executive officer, will provide an overview of the company at the upcoming 28th Annual ROTH Conference to […]

Feb 02 2016

OticPharma to Present at the 2016 BIO CEO & Investor Conference

IRVINE, Calif., and REHOVOT, Israel, Feb. 2, 2016 /PRNewswire/ — OticPharma, Ltd., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced that Gregory J. Flesher, chief executive officer, will present an overview of the company at the upcoming 18th Annual BIO CEO & […]

Nov 30 2015

OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors

IRVINE, Calif. and REHOVOT, Israel, Nov. 30, 2015 /PRNewswire/ — OticPharma, Ltd., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced the appointment of Keith A. Katkin as chairman of the company’s board of directors. “We are happy to welcome Keith to the […]

Nov 11 2015

OticPharma Appoints Dr. Catherine C. Turkel as Chief Development Officer

IRVINE, Calif. and REHOVOT, Israel, Nov. 11, 2015 /PRNewswire/ — OticPharma, Inc., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) disorders, today announced that it has appointed Catherine C. Turkel, Pharm.D., Ph.D. to the position of senior vice president clinical research and development and chief […]